GlassScriptPhysician profile
Ailleen Jacob
NPI 1871143883
$1,178.93
in general payments reported to CMS, 2019-2025
14 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.21 · 2020: $130 · 2021: $390 · 2022: $129 · 2023: $36.51 · 2024: $361 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $301.14 | 2021-2024 | Gts100_glaukos Istent Trabecular Micro-Bypass Stent System |
| Alcon Vision LLC | $204.35 | 2023-2025 | Precision7, Total30, Dailies Total1 |
| Kala Pharmaceuticals, INC. | $172.63 | 2021 | |
| Mallinckrodt Hospital Products INC. | $165.71 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $148.87 | 2020-2024 | Acuvue |
| Novartis Pharmaceuticals Corporation | $41.35 | 2020-2021 | |
| Amgen INC. | $27.59 | 2024 | Tepezza |
| Allergan, INC. | $21.35 | 2021 | |
| Oyster Point Pharma, INC. | $20.89 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Omeros Corporation | $15.89 | 2021 | |
| Akorn Operating Company LLC | $15.10 | 2021 | |
| Coopervision INC. | $14.61 | 2023 | Myday Contact Lens |
| Merz North America, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ailleen Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.